Key result
Exercise-induced pulmonary hypertension linked to ~136% greater risk of HF death or hospitalization in ≥moderate AS.
Why the study?
To describe exercise hemodynamics across cardiac damage stages and evaluate the incremental prognostic impact of cardiac damage stage and exercise-induced pulmonary hypertension in symptomatic moderate or asymptomatic severe AS.
Does cardiac damage staging and exercise-induced pulmonary hypertension predict heart failure death and hospitalization in patients with ≥moderate aortic stenosis?
Cohort (n=436)
Does cardiac damage staging and exercise-induced pulmonary hypertension predict heart failure death and hospitalization in patients with ≥moderate aortic stenosis?
Hazard Ratio: 2.36 (95% CI 1.1–5.07)
p-value: p=0.03
In patients with ≥moderate aortic stenosis, cardiac damage stage and exercise-induced pulmonary hypertension independently predict heart failure outcomes, with exPHT providing significant incremental prognostic value in early damage stages.
Cardiac damage staging may refine HF risk prediction in aortic stenosis; leaves open prospective validation before guiding decisions.
AIM: To describe exercise hemodynamics across cardiac damage stages and evaluate the incremental prognostic impact of cardiac damage stage and exercise-induced pulmonary hypertension (exPHT) in patients with symptomatic moderate aortic stenosis (AS) and asymptomatic severe AS. METHODS AND RESULTS: A total of 436 consecutive patients with ≥moderate AS (74 ± 10 years, 32% women, 56% severe AS) underwent cardiopulmonary exercise testing with echocardiography. The primary endpoint was heart failure (HF) death and HF hospitalizations. Cardiac damage stage was 0 in 93 patients, 1 (LV damage) in 135, 2 (LA/mitral damage) in 135, and 3-4 (pulmonary vasculature/tricuspid or RV damage) in 73. Higher stages were associated with worse exercise capacity and hemodynamics. Over a median follow-up of 37 months, 65 patients met the primary endpoint. After adjustment for age, AS severity, and aortic valve replacement, cardiac damage stage and exPHT were independently associated with HF outcomes (HR per stage increase 1.51 [1.26-1.82]; p < 0.001; exPHT HR 2.36 [1.10-5.07]; p = 0.03). exPHT improved risk stratification in early-stage disease (stages 1-2), conferring an approximately fivefold higher risk of HF events in patients with exPHT (HR 4.45 [1.58-12.59]; p < 0.01). CONCLUSIONS: In patients with ≥moderate AS and discordant symptoms, cardiac damage stage and exPHT independently refined HF risk stratification. ExPHT provides incremental prognostic value in early damage stages (1-2), representing over half of the cohort, supporting a stepwise approach of routine damage staging with selective with exPHT assessment with exercise echocardiography in this subgroup to guide more personalized management and potentially optimize AVR timing.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2026) conducted a cohort in ≥moderate aortic stenosis (n=436). Exercise-induced pulmonary hypertension (exPHT) vs. Absence of exPHT was evaluated on Heart failure (HF) death and HF hospitalizations (HR 2.36, 95% CI 1.10-5.07, p=0.03). Exercise-induced pulmonary hypertension independently increased the risk of heart failure death or hospitalization in patients with ≥moderate aortic stenosis (HR 2.36; 95% CI 1.10-5.07; p=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: